Tarsier Pharma Ltd（TARX）美股招股说明书 F-1（2026-06-16修订版）（英文版）（13页）.pdf

1、F-1/A 1 ea0270166-11.htm REGISTRATION STATEMENTAs filed with the Securities and Exchange Commission on June 16,2026.Registration Number 333-295210UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_AMENDMENT NO.3TOFORM F-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933_Tarsier

2、Pharma Ltd.(Exact Name of Registrant as Specified in its Charter)_State of Israel2834N/A(State or otherjurisdiction ofincorporation ororganization)(Primary StandardIndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)10 HaMaapilim St.Zichron Yaacov,Israel 3093765Tel:+972-4-639-8050

3、(Address,Including Zip Code,and Telephone Number,Including Area Code,ofRegistrants Principal Executive Offices)_Puglisi&Associates850 Library Ave.,Suite 204Newark,DE19711Tel:(302)738-6680(Name,Address,Including Zip Code,and Telephone Number,Including Area Code,ofAgent for Service)_with copies to:Bar

4、ryI.Grossman,Esq.Justin Grossman,Esq.Nahal A.Nellis,Esq.Ellenoff Grossman&Schole LLP1345 Avenue of theAmericasNewYork,NY10105(212)370-1300Yael Shimon-Many,Adv.Benjamin Waltuch,Adv.,Yuval Mor,Adv.,Pearl Cohen Zedek LatzerBaratz,121 Menachem Begin Rd.,53rd FloorTel Aviv-Jaffa,Israel6701203+972-3-303-9

5、000Joseph M.Lucosky,Esq.Lawrence Metelitsa,Esq.Sebastian A.Bacon,Esq.Lucosky Brookman LLP101 Wood Avenue SouthWoodbridge,New Jersey08830(732)395-4400_Approximate date of commencement of proposed sale to public:As soon as practicable after the effective date hereof.If any of the securities being regi

6、stered on this Form are to be offered on a delayed orcontinuous basis pursuant to Rule415 under the Securities Actof1933,check the following box.If this Form is filed to register additional securities for an offering pursuant toRule 462(b)under the Securities Act,check the following box and list the